Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Bladder training could be as good as pelvic floor therapy for urgency incontinence

NCT ID NCT07259148

Symptom relief Sponsor: Emilio José Dávila Álvarez Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a simple behavioral program—like timed bathroom visits and avoiding bladder irritants—works as well as supervised pelvic floor muscle training when both are combined with standard medication for urgency urinary incontinence. Eighty women with this condition will be randomly assigned to one of the two approaches for 8 weeks. The goal is to see if the behavioral option, which is easier to access in low-resource settings, is not inferior to pelvic floor training in reducing incontinence symptoms.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Oxybutynin / Mirabegron
What this could lead to
If behavioral therapy works as well as pelvic floor training, it could offer a simpler, low-cost option for women with urgency incontinence, especially in areas with limited access to specialized physiotherapy.
What could go wrong
This is a small, early-stage trial with only 80 participants, so results may not apply to all women. The behavioral approach might not be as effective as pelvic floor training, and side effects from medication are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * Women aged ≥18 years. * Symptoms of urgency urinary incontinence (UUI) or mixed urinary incontinence with predominance of urgency, with duration ≥3 months. * Clinical diagnosis of UUI based on history, physical examination, and a 3-day bladder diary. * Predominance of urgency defined as: at least 50% of total recorded episodes in the bladder diary correspond to urgency (with or without leakage). * Baseline ICIQ-SF score ≥6. * Ability to attend scheduled visits and comply with assigned intervention. * Signed informed consent. Exclusion Criteria: * Pure stress urinary incontinence. * Mixed urinary incontinence with predominance of stress defined as: more than 70% of episodes in the 3-day bladder diary are triggered by physical effort. * Symptomatic advanced pelvic organ prolapse (POP-Q stage ≥III). * Active or recent urinary tract infection (within the last 7 days). * Prior use of anticholinergics or β3-agonists that cannot be discontinued for a 14-day washout period. * Pregnancy or breastfeeding. * Neurological or psychiatric disorders affecting bladder function, record-keeping, or adherence. * Cognitive or functional difficulty preventing understanding or completion of study procedures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Urgency urinary incontinence are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

overactive bladder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Urgency urinary incontinence

Contacts and locations

Locations

  • Hospital Militar Escuela Dr. Alejandro Dávila Bolaños

    Managua, Managua Department, Nicaragua

More trials for these conditions

Other studies related to the condition(s) this trial covers.